Total Payments
$1,924
2024 Payments
$424.73
Companies
12
Transactions
76
Medicare Patients
1,716
Medicare Billing
$213,808

Payment Breakdown by Category

Food & Beverage$1,834 (95.3%)
Gifts$89.99 (4.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,834 75 95.3%
Gift $89.99 1 4.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $731.53 37 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $284.59 10 $0 (2024)
Celgene Corporation $265.94 18 $0 (2024)
Gilead Sciences Inc $250.00 2 $0 (2017)
Valeant Pharmaceuticals North America LLC $123.57 2 $0 (2017)
Merck Sharp & Dohme Corporation $100.00 1 $0 (2017)
Boston Scientific Corporation $40.00 1 $0 (2019)
Shionogi Inc $29.31 1 $0 (2019)
Celltrion USA Inc. $28.88 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $26.86 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $424.73 19 ABBVIE INC. ($227.38)
2023 $428.99 25 ABBVIE INC. ($222.33)
2022 $439.67 21 ABBVIE INC. ($260.07)
2021 $87.62 4 Celgene Corporation ($39.01)
2019 $69.31 2 Boston Scientific Corporation ($40.00)
2017 $473.57 5 Gilead Sciences Inc ($250.00)

All Payment Transactions

76 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/17/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $23.65 General
Category: IMMUNOLOGY
11/06/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $30.21 General
Category: IMMUNOLOGY
11/06/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $0.78 General
Category: IMMUNOLOGY
10/31/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $28.88 General
Category: ONCOLOGY
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $29.76 General
Category: INTERNAL MEDICINE
08/07/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $31.25 General
Category: INTERNAL MEDICINE
07/23/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $23.62 General
Category: IMMUNOLOGY
06/26/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $25.89 General
Category: IMMUNOLOGY
05/16/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $28.71 General
Category: IMMUNOLOGY
05/01/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $26.04 General
Category: INTERNAL MEDICINE
04/17/2024 ABBVIE INC. HUMIRA (Biological), RINVOQ Food and Beverage In-kind items and services $21.00 General
Category: IMMUNOLOGY
04/17/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $2.32 General
Category: IMMUNOLOGY
04/04/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $22.67 General
Category: Immunology
03/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $26.33 General
Category: IMMUNOLOGY
02/28/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $27.17 General
Category: INTERNAL MEDICINE
02/21/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.86 General
Category: Neuroscience
02/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.13 General
Category: IMMUNOLOGY
01/24/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $14.72 General
Category: Neuroscience
01/04/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $28.74 General
Category: IMMUNOLOGY
12/06/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.70 General
Category: Neuroscience
11/15/2023 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $28.43 General
Category: IMMUNOLOGY
11/01/2023 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $26.59 General
Category: INTERNAL MEDICINE
10/19/2023 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.53 General
Category: IMMUNOLOGY
10/04/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $17.06 General
Category: Neuroscience
10/04/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $1.71 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 459 525 $697,015 $61,242
2022 11 466 531 $578,828 $60,173
2021 12 436 492 $550,087 $55,692
2020 11 355 393 $385,994 $36,701
Total Patients
1,716
Total Services
1,941
Medicare Billing
$213,808
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 87 141 $91,650 $15,252 16.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 104 107 $123,035 $12,714 10.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 49 49 $157,270 $11,087 7.0%
43246 Insertion of stomach tube using a flexible endoscope Facility 2023 20 20 $52,755 $3,879 7.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 26 26 $24,685 $3,687 14.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 35 41 $21,180 $3,221 15.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 48 48 $130,210 $3,189 2.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 25 28 $18,140 $2,949 16.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 33 33 $58,150 $2,790 4.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 20 20 $10,700 $1,400 13.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $9,240 $1,074 11.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 91 137 $89,050 $15,129 17.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 82 83 $95,438 $10,500 11.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 37 37 $104,340 $9,210 8.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 48 61 $35,075 $5,804 16.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 27 27 $25,860 $4,387 17.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 42 43 $67,080 $3,811 5.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 43 43 $101,910 $3,474 3.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 44 47 $21,150 $3,420 16.2%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 25 25 $22,250 $2,357 10.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 15 16 $8,560 $1,079 12.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 12 12 $8,115 $1,001 12.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 61 77 $49,630 $9,236 18.6%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 32 32 $90,240 $7,226 8.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 54 54 $62,092 $6,962 11.2%

About Dr. Harish Guddati, M.D

Dr. Harish Guddati, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891040911.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harish Guddati, M.D has received a total of $1,924 in payments from pharmaceutical and medical device companies, with $424.73 received in 2024. These payments were reported across 76 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,834).

As a Medicare-enrolled provider, Guddati has provided services to 1,716 Medicare beneficiaries, totaling 1,941 services with total Medicare billing of $213,808. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

Products in Payments

  • RINVOQ (Biological) $436.67
  • ZEPOSIA (Drug) $292.80
  • ENTYVIO (Biological) $284.59
  • Epclusa (Drug) $250.00
  • SKYRIZI (Biological) $183.89
  • HUMIRA (Biological) $110.97
  • ZEPATIER (Drug) $100.00
  • ORCAPOD (Device) $40.00
  • XIFAXAN (Drug) $33.58
  • Mulpleta (Drug) $29.31
  • VEGZELMA (Biological) $28.88
  • OMVOH (Drug) $22.67
  • AMJEVITA (Biological) $20.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx